This ASX dividend stock is noticeably down from its all-time high. It could be a good time to invest in the business.
Audinate may not be the most well-known business on the ASX, but it claims to be one of the leaders in the ... the business has fallen so much. As the chart below shows, the last 12 months have ...
Exchange traded funds (“ETFs”) continue to rise in popularity with over half of Australian investors now holding at least one ...
4d
Market Index News on MSNShould you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?
The ASX 200 gold stock mines some 6 million ounces of gold every year. The post The $85 billion ASX 200 gold stock trading at ...
Key Insights Institutions' substantial holdings in Capricorn Metals implies that they have significant influence ...
Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Reece (ASX ... year, all while growing ...
Are these stocks at valuations that are too good to ignore? The post Near 52-week lows, are these ASX 300 shares now ...
Stockhead on MSN17d
Who made the gains in January? Here are the top ASX resources winnersAusQuest was the star player with a potentially huge copper discovery in Peru, but gold stocks dominated the ASX resources ...
All the figures in Commonwealth Bank’s results – and there were 128 pages of them – are about the one number that was not ...
Eye diseases specialist Opthea has treated the last patient in the first of two pivotal phase III trials. The first of Opthea ...
All the figures in Commonwealth Bank’s results – and there were 128 pages of them – are about the one number that was not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results